ROYAL BANK OF CANADA - COCRYSTAL PHARMA INC ownership

COCRYSTAL PHARMA INC's ticker is and the CUSIP is 19188J409. A total of 22 filers reported holding COCRYSTAL PHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of COCRYSTAL PHARMA INC
ValueSharesWeighting
Q3 2023$090.0%0.00%
Q2 2023$090.0%0.00%
Q1 2023$090.0%0.00%
Q4 2022$090.00%
Other shareholders
COCRYSTAL PHARMA INC shareholders Q1 2023
NameSharesValueWeighting ↓
Tower Research Capital LLC (TRC) 3,348$6,2610.00%
JPMORGAN CHASE & CO 1,744$3,2610.00%
Renaissance Technologies 126,228$2360.00%
ROYAL BANK OF CANADA 9$00.00%
VANGUARD GROUP INC 275,656$515,4770.00%
FMR LLC 187$3500.00%
BANK OF AMERICA CORP /DE/ 9,028$16,8820.00%
WELLS FARGO & COMPANY/MN 89$1660.00%
NORTHERN TRUST CORP 12,207$22,8280.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of COCRYSTAL PHARMA INC shareholders